Table 4.

Summary of meta-analyses which investigated preventive effect of nucleos(t)ide analogues on hepatocellular carcinoma recurrence in patients who underwent curative treatments

Ref.	No. of studies	No. of patients (T/C)	OR (95%CI)	P
Miao et al[98]
1 yr recurrence	2	119 (46/73)	0.59 (0.24-1.43)	0.24
2 yr recurrence	2	119 (46/73)	0.82 (0.34-1.74)	0.60
Wong et al[65]	9	555 (204/347)	0.59 (0.35-0.97)	0.04
Sun et al[78]	13	6350 (1227/5123)	0.66 (0.54-0.80)	< 0.0001
Zhou et al[79]	8	6127 (NS)	0.69 (0.59-0.80)	< 0.00001

NS: Not significant; T: Treatment group; C: Control group.